Max Wolff
Director of Research and Training at the MIND Foundation; psychologist and psychotherapist
Data updated
Research Footprint
Max Wolff appears in 7 tracked papers (2020–2026), most studied alongside Psilocybin and Placebo, across Depressive Disorders, Treatment-Resistant Depression (TRD) and PTSD.
Most-cited paper: Learning to Let Go: A Cognitive-Behavioral Model of How Psychedelic Therapy Promotes Acceptance (184 citations).
Frequent co-authors: Ricarda Evens, Lea Mertens and Henrik Jungaberle.
Background & Research
Dr. rer. nat. Max Wolff is a psychologist and psychotherapist based in Berlin. He serves as Director of Research and Training at the MIND Foundation, directs its Augmented Psychotherapy Training program, and works as a psychotherapist at OVID Clinic Berlin. His research focuses on the psychological mechanisms and contextual conditions of change in psychedelic experiences, and he has been involved in clinical studies including the EPIsoDE psilocybin trial.
Key Impact
He is a notable contributor to psychedelic psychotherapy research, especially on context, acceptance, therapeutic mechanisms, and the EPIsoDE psilocybin trial.
Collaboration Network
8 collaborators· click a node to visit their profile
Full network →Compounds
Topics
Top Collaborators
Affiliations
Institutions, companies, and organisations Max Wolff is associated with.
MIND Foundation
Non-ProfitEuropean nonprofit research and implementation organization that organizes the INSIGHT Conference and allied public/professional events.
View stakeholder →Charité – Universitätsmedizin Berlin
hospitalThe MIND Foundation partnered with Charité – Universitätsmedizin Berlin, one of Europe's largest university hospitals. Charité is affiliated with Humboldt University and Free University Berlin. This partnership sees researchers at the hospital carrying out clinical studies with psilocybin in patients with treatment-resistant depression. Studies also take place concurrently at the Central Institute for Mental Health Mannheim.
View stakeholder →